Experimental vaccine SurVaxM shows promise in delaying the return of aggressive brain tumor - KPRC2
, in fall 2020. Two and a half years later, he’s still traveling and enjoying life — a rarity for a cancer with an average survival time of just 12 to 18 months.
Wishman, 61, of Buffalo, New York, attributes that to an experimental vaccine that’s designed to delay the progression of the tumor. The vaccine, called SurVaxM, targets a protein found in tumors called survivin, named for the role it’s thought to play in the survival of cancer cells. Get rid of survivin, the thinking goes, and the cancer cells will die.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Experimental vaccine shows promise in delaying the return of aggressive brain tumorThe vaccine, called SurVaxM, was shown to nearly double the survival time in a trial of 63 patients. Researchers now hope to confirm the findings in a larger trial.
Les mer »
Experimental treatment could work against prion diseases like CJDPrion diseases are invariably fatal, but an experimental genetic treatment has dramatically extended the lifespans of infected mice
Les mer »
‘Isolated’ John Calipari has program in ‘complete disarray’: Kentucky sports radio hostThere is apparently deep worry around the program about what comes next under John Calipari’s regime.
Les mer »
Heritage Foundation vs. Prince Harry in a royal dust-upOpinion: Heritage Foundation vs. Prince Harry in a royal dust-up
Les mer »
Yellowstone: Wes Bentley Shares S05 Update; Jamie/John/Beth DynamicYellowstoneTV star WesBentley offered an update on the fifth & final season, discussed the upcoming JamieDutton/JohnDutton/BethDutton dynamic, and more. / ParamountNetwork Yellowstone TaylorSheridan
Les mer »
'Never Have I Ever': Is This the End of the Series? Cast on That TeaseJohn McEnroe couldn't help leaving his mark one last time in the series finale.
Les mer »